← SynDRA
tetraethylenepentamine
SynDRA canonical compound SYN0043074 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | SOD2 |
|---|
| Mechanism of action | Superoxide dismutase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Superoxide dismutase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- CTRC
- EHMT2
- LMNA
- MDH1
- NR1H4
- PPARG
- TDP1
- TP53
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Bile-acid Binding Activity
- Anion Exchange Resins
- Antimetabolites
- Hypolipidemic Agents
- Ion Exchange Resins
- Lipid Regulating Agents
- Sequestering Agents
- Bile Acid Sequestrant
ATC classes
- C10A · LIPID MODIFYING AGENTS, PLAIN
Cross-references
Synonyms
- COLESTID
- COLESTIPOL HYDROCHLORIDE
- Colestid
- FLAVORED COLESTID
- RAUTENSIN
- RAUWILOID
- Tetren
- 1,4,7,10,13-Pentaazatridecane
- Tetraethylene pentamine
- Tetraethylpentylamine
- 1,11-Diamino-3,6,9-triazaundecane
- 3,6,9-Triazaundecamethylenediamine
- DEH 26
- 3,6,9-Triazaundecane-1,11-diamine
- Ancamine TEPA
- TETRAEN
- YZD1C9KQ28
- INSULCURE 9
- NSC 88603
- DTXCID006108
- CHEBI:49798
- TH 160
- 3,6,9-TRIAZA-1,11-DIAMINOUNDECANE
- T-11509
- RefChem:188579
- Tetrene
- MFCD00008168
- NCGC00090964-02
- CAS-112-57-2
- PAW
- CCRIS 6275
- HSDB 5171
- EINECS 203-986-2
- UN2320
- UNII-YZD1C9KQ28
- BRN 0506966
- AI3-10049
- C8H23N5
Reported adverse events
- Chest pain
- Constipation
- Headache
- Hypersensitivity
- Musculoskeletal pain
- Peptic ulcer
- Rash
- Urticaria
Look up tetraethylenepentamine in the interactive SynDRA portal →